lifestyle.longislandreport.org

Author: ImmuCell Corporation

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

April 13, 2026
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

April 8, 2026
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

March 18, 2026
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

March 4, 2026
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

February 18, 2026